Steven Lo - 06 Jun 2022 Form 4 Insider Report for Zosano Pharma Corp

Role
Chief Executive Officer, Director
Signature
/s/ Steven Lo
Issuer symbol
N/A
Transactions as of
06 Jun 2022
Net transactions value
-$314
Form type
4
Filing time
07 Jun 2022, 19:37:48 UTC
Previous filing
01 Apr 2022
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZSAN Common Stock Sale $314 -442 -3.2% $0.7100* 13,163 06 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
F2 Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.